Hillhouse Capital Management, Ltd., 10% Owner at Apellis Pharmaceuticals, Inc. (APLS), bought 3,527,152 shares at $14.00 ($20.0M) on 2017-11-13, disclosed to the SEC on 2017-11-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,098,581 | $0 | 0.0% |
| 2 | $14.00 | 1,428,571 | $20.0M | 100.0% |
| Total | $5.67 avg | 3,527,152 | $20.0M | 100% |